Skip to content
10-Q

Quarterly Report

Repare Therapeutics Inc.

0001193125-25-283336

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 42.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 43.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 42.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 42.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 42.38M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$42.82M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$49.12M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $72.83M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $84.72M
Stockholders Equity Q3 2025 · Sep 30, 2025 $115.13M
Stockholders Equity Q3 2025 · Jun 30, 2025 $110.41M
Stockholders Equity Q3 2025 · Mar 31, 2025 $125.1M
Stockholders Equity Q3 2025 · Dec 31, 2024 $151.13M
Stockholders Equity Q3 2025 · Sep 30, 2024 $174.96M
Stockholders Equity Q3 2025 · Jun 30, 2024 $203.68M
Stockholders Equity Q3 2025 · Mar 31, 2024 $231.95M
Stockholders Equity Q3 2025 · Dec 31, 2023 $212.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $25.29M
Total Liabilities Q3 2025 · Sep 30, 2025 $11.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $25.38M
Current Assets Q3 2025 · Sep 30, 2025 $124.43M
Current Assets Q3 2025 · Dec 31, 2024 $171.15M
Total Assets Q3 2025 · Sep 30, 2025 $126.75M
Total Assets Q3 2025 · Dec 31, 2024 $176.51M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.08
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.81
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.32
Eps Basic Q3 2025 · Sep 30, 2025 $0.08
Eps Basic Q3 2025 · Sep 30, 2025 −$1.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.81
Eps Basic Q3 2025 · Sep 30, 2024 −$1.32
Sga Expense Q3 2025 · Sep 30, 2025 $4.55M
Sga Expense Q3 2025 · Sep 30, 2025 $18.23M
Sga Expense Q3 2025 · Sep 30, 2024 $6.44M
Sga Expense Q3 2025 · Sep 30, 2024 $23.38M
Rd Expense Q3 2025 · Sep 30, 2025 $7.5M
Rd Expense Q3 2025 · Sep 30, 2025 $42.06M
Rd Expense Q3 2025 · Sep 30, 2024 $28.4M
Rd Expense Q3 2025 · Sep 30, 2024 $91.45M
Net Income Q3 2025 · Sep 30, 2025 $3.26M
Net Income Q3 2025 · Sep 30, 2025 −$43.53M
Net Income Q3 2025 · Sep 30, 2024 −$34.41M
Net Income Q3 2025 · Sep 30, 2024 −$56.02M
Operating Income Q3 2025 · Sep 30, 2025 $1.13M
Operating Income Q3 2025 · Sep 30, 2025 −$47.84M
Operating Income Q3 2025 · Sep 30, 2024 −$36.37M
Operating Income Q3 2025 · Sep 30, 2024 −$62.88M